Literature DB >> 28126969

The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation.

Nicole Stadler1, Astrid Hasibeder1, Pamela Aranda Lopez1, Daniel Teschner1, Alexander Desuki1, Oliver Kriege1, Alexander N R Weber2, Christoph Schulz1,3, Christian Michel1, Georg Heβ1, Markus P Radsak4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28126969      PMCID: PMC5477622          DOI: 10.3324/haematol.2016.152017

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4.

Authors:  Caroline A Jefferies; Sarah Doyle; Cornelia Brunner; Aisling Dunne; Elizabeth Brint; Claudia Wietek; Eva Walch; Thomas Wirth; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

2.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock.

Authors:  A Bouchon; F Facchetti; M A Weigand; M Colonna
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

3.  Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia.

Authors:  Constantine S Tam; Susan O'Brien; William Wierda; Hagop Kantarjian; Sijin Wen; Kim-Anh Do; Deborah A Thomas; Jorge Cortes; Susan Lerner; Michael J Keating
Journal:  Blood       Date:  2008-04-14       Impact factor: 22.113

4.  Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.

Authors:  Fabio Da Roit; Patrick J Engelberts; Ronald P Taylor; Esther C W Breij; Giuseppe Gritti; Alessandro Rambaldi; Martino Introna; Paul W H I Parren; Frank J Beurskens; Josée Golay
Journal:  Haematologica       Date:  2014-10-24       Impact factor: 9.941

5.  Btk is a positive regulator in the TREM-1/DAP12 signaling pathway.

Authors:  Tereza Ormsby; Eva Schlecker; Janina Ferdin; Anja Sibylle Tessarz; Pavla Angelisová; Afitap Derya Köprülü; Michael Borte; Klaus Warnatz; Ilka Schulze; Wilfried Ellmeier; Václav Horejsí; Adelheid Cerwenka
Journal:  Blood       Date:  2011-06-09       Impact factor: 22.113

Review 6.  Neutrophil migration in infection and wound repair: going forward in reverse.

Authors:  Sofia de Oliveira; Emily E Rosowski; Anna Huttenlocher
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

7.  Distinct signaling cascades of TREM-1, TLR and NLR in neutrophils and monocytic cells.

Authors:  Steve Prüfer; Michael Weber; Daniel Sasca; Daniel Teschner; Catherine Wölfel; Pamela Stein; Michael Stassen; Hansjörg Schild; Markus P Radsak
Journal:  J Innate Immun       Date:  2013-11-21       Impact factor: 7.349

Review 8.  The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation and function.

Authors:  D J Rawlings; O N Witte
Journal:  Semin Immunol       Date:  1995-08       Impact factor: 11.130

9.  Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.

Authors:  Clare Sun; Xin Tian; Yuh Shan Lee; Sreenivasulu Gunti; Andrew Lipsky; Sarah E M Herman; Dalia Salem; Maryalice Stetler-Stevenson; Constance Yuan; Lela Kardava; Susan Moir; Irina Maric; Janet Valdez; Susan Soto; Gerald E Marti; Mohammed Z Farooqui; Abner L Notkins; Adrian Wiestner; Georg Aue
Journal:  Blood       Date:  2015-09-03       Impact factor: 22.113

10.  Bruton's Tyrosine Kinase (BTK) and Vav1 contribute to Dectin1-dependent phagocytosis of Candida albicans in macrophages.

Authors:  Karin Strijbis; Fikadu G Tafesse; Gregory D Fairn; Martin D Witte; Stephanie K Dougan; Nicki Watson; Eric Spooner; Alexandre Esteban; Valmik K Vyas; Gerald R Fink; Sergio Grinstein; Hidde L Ploegh
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

View more
  17 in total

1.  Neutrophil extracellular traps impair fungal clearance in a mouse model of invasive pulmonary aspergillosis.

Authors:  Astrid Alflen; Pamela Aranda Lopez; Ann-Kathrin Hartmann; Joachim Maxeiner; Markus Bosmann; Arjun Sharma; Johannes Platten; Frederic Ries; Hendrik Beckert; Wolfram Ruf; Markus P Radsak
Journal:  Immunobiology       Date:  2019-11-13       Impact factor: 3.144

2.  Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.

Authors:  Michail S Lionakis; Kieron Dunleavy; Mark Roschewski; Brigitte C Widemann; John A Butman; Roland Schmitz; Yandan Yang; Diane E Cole; Christopher Melani; Christine S Higham; Jigar V Desai; Michele Ceribelli; Lu Chen; Craig J Thomas; Richard F Little; Juan Gea-Banacloche; Sucharita Bhaumik; Maryalice Stetler-Stevenson; Stefania Pittaluga; Elaine S Jaffe; John Heiss; Nicole Lucas; Seth M Steinberg; Louis M Staudt; Wyndham H Wilson
Journal:  Cancer Cell       Date:  2017-05-25       Impact factor: 31.743

3.  Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.

Authors:  Georgios Chamilos; Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

4.  Atypical Presentation of Severe Fungal Necrotizing Fasciitis in a Patient with X-Linked Agammaglobulinemia.

Authors:  Chai Teng Chear; Revathy Nallusamy; Kwai Cheng Chan; Ratna Mohd Tap; Mohd Farid Baharin; Sharifah Nurul Husna Syed Yahya; Prasobhan Bala Krishnan; Saharuddin Bin Mohamad; Adiratna Mat Ripen
Journal:  J Clin Immunol       Date:  2021-03-13       Impact factor: 8.317

Review 5.  Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity.

Authors:  Alexander N R Weber; Zsofia Bittner; Xiao Liu; Truong-Minh Dang; Markus Philipp Radsak; Cornelia Brunner
Journal:  Front Immunol       Date:  2017-11-08       Impact factor: 7.561

6.  CD11b Regulates Fungal Outgrowth but Not Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis.

Authors:  Daniel Teschner; Anna Cholaszczyńska; Frederic Ries; Hendrik Beckert; Matthias Theobald; Stephan Grabbe; Markus Radsak; Matthias Bros
Journal:  Front Immunol       Date:  2019-02-04       Impact factor: 7.561

7.  Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus.

Authors:  Damien Blez; Marion Blaize; Carole Soussain; Alexandre Boissonnas; Aïda Meghraoui-Kheddar; Natacha Menezes; Anaïs Portalier; Christophe Combadière; Véronique Leblond; David Ghez; Arnaud Fekkar
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

Review 8.  Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.

Authors:  Stefan F H Neys; Rudi W Hendriks; Odilia B J Corneth
Journal:  Front Cell Dev Biol       Date:  2021-06-04

9.  Idelalisib impairs TREM-1 mediated neutrophil inflammatory responses.

Authors:  Astrid Alflen; Nicole Stadler; Pamela Aranda Lopez; Daniel Teschner; Matthias Theobald; Georg Heß; Markus P Radsak
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

10.  [Cryptococcal meningitis in the treatment of CLL with ibrutinib: a case report and literature review].

Authors:  H Zhang; X H Zhang; P Chen; B Z Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.